相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury
Chiyu He et al.
STEM CELL REVIEWS AND REPORTS (2023)
The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds
Tim Brecklinghaus et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2022)
Recapitulating lipid accumulation and related metabolic dysregulation in human liver-derived organoids
Ling Wang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2022)
Why 90 % of clinical drug development fails and how to improve it?
Duxin Sun et al.
ACTA PHARMACEUTICA SINICA B (2022)
Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond
Ruizhi Gu et al.
DRUG METABOLISM AND DISPOSITION (2022)
An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice
Chuang-Wei Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making
Xiaoqing Chang et al.
TOXICS (2022)
Hepatic bile acid synthesis and secretion: Comparison of in vitro methods
Veronique M. P. De Bruijn et al.
TOXICOLOGY LETTERS (2022)
Human Cholangiocytes Form a Polarized and Functional Bile Duct on Hollow Fiber Membranes
Zhenguo Wang et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Toward Realistic Dosimetry In Vitro: Determining Effective Concentrations of Test Substances in Cell Culture and Their Prediction by an In Silico Mass Balance Model
Dunja Dimitrijevic et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2022)
Valproic acid induced liver injury: An insight into molecular toxicological mechanism
Devaraj Ezhilarasan et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2022)
A mechanism of perhexiline's cytotoxicity in hepatic cells involves endoplasmic reticulum stress and p38 signaling pathway
Zhen Ren et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?
Junya Shiota et al.
HEPATOLOGY (2021)
A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies
Ana S. Serras et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data
Jaydeep Yadav et al.
DRUG METABOLISM REVIEWS (2021)
Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications
Qianqian Xu
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
SULT genetic polymorphisms: physiological, pharmacological and clinical implications
Katsuhisa Kurogi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro
Sarah Kammerer
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
New In Vitro-In Silico Approach for the Prediction of In Vivo Performance of Drug Combinations
Cristiana Correia et al.
MOLECULES (2021)
Safer chemicals using less animals: kick-off of the European ONTOX project
Mathieu Vinken et al.
TOXICOLOGY (2021)
Establishing a 3D In Vitro Hepatic Model Mimicking Physiologically Relevant to In Vivo State
Hyun Kyoung Kang et al.
CELLS (2021)
Cross-species analysis of hepatic cytochrome P450 and transport protein expression
Helen Hammer et al.
ARCHIVES OF TOXICOLOGY (2021)
Organoids to model liver disease
Sandro Nuciforo et al.
JHEP REPORTS (2021)
Drugs and hepatic transporters: A review
Alexander Jetter et al.
PHARMACOLOGICAL RESEARCH (2020)
Genetic polymorphisms of human hepatic OATPs: functional consequences and effect on drug pharmacokinetics
Yingmin Nie et al.
XENOBIOTICA (2020)
Large-Scale Production of LGR5-Positive Bipotential Human Liver Stem Cells
Kerstin Schneeberger et al.
HEPATOLOGY (2020)
Assessing Toxicity with Human Cell-Based In Vitro Methods
Daniele Zink et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors
E. E. J. Kasteel et al.
ARCHIVES OF TOXICOLOGY (2020)
Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation
Xihui Zhang et al.
CRITICAL REVIEWS IN TOXICOLOGY (2020)
Use of 3D Human Liver Organoids to Predict Drug-Induced Phospholipidosis
Ji-Young Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Establishment of patient-derived cancer organoids for drug-screening applications
Else Driehuis et al.
NATURE PROTOCOLS (2020)
Drug Withdrawal Due to Safety: A Review of the Data Supporting Withdrawal Decision
Nuno Sales Craveiro et al.
CURRENT DRUG SAFETY (2020)
The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
Li Di
CURRENT DRUG METABOLISM (2019)
Liver organoids: from basic research to therapeutic applications
Nicole Prior et al.
GUT (2019)
Next-Generation Liver Medicine Using Organoid Models
Soheil Akbari et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials Is it Time to Rethink Our Current Approach?
Gail A. Van Norman
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions
Sabine U. Vorrink et al.
TOXICOLOGICAL SCIENCES (2018)
Characterization of hepatocyte-based in vitro systems for reliable toxicity testing
Mathieu Vinken et al.
ARCHIVES OF TOXICOLOGY (2018)
In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity
Kun Zhang et al.
CELL STEM CELL (2018)
Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors
Shalenie P. den Braver-Sewradj et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers
Michael H. Court et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools
Naiem T. Issa et al.
CURRENT DRUG METABOLISM (2017)
Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury
Catherine C. Bell et al.
DRUG METABOLISM AND DISPOSITION (2017)
Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man
Sanja Dragovic et al.
ARCHIVES OF TOXICOLOGY (2016)
In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries
Doshi Utkarsh et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Non-cytochrome P450-mediated bioactivation and its toxicological relevance
Jinping Gan et al.
DRUG METABOLISM REVIEWS (2016)
Role of Hepatic Drug Transporters in Drug Development
Houfu Liu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis
Laia Tolosa et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease
Catherine C. Bell et al.
SCIENTIFIC REPORTS (2016)
Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures
Karsten Boehnke et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Meritxell Huch et al.
CELL (2015)
Minimizing DILI risk in drug discovery - A screening tool for drug candidates
S. Schadt et al.
TOXICOLOGY IN VITRO (2015)
Sex Differences in Liver Toxicity-Do Female and Male Human Primary Hepatocytes React Differently to Toxicants In Vitro?
Milena Mennecozzi et al.
PLOS ONE (2015)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Three-Dimensional HepaRG Model As An Attractive Tool for Toxicity Testing
Sofia B. Leite et al.
TOXICOLOGICAL SCIENCES (2012)
TOXICITY TESTING IN THE 21ST CENTURY: A VISION AND A STRATEGY
Daniel Krewski et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2010)
A Comparative Study of Genome-Wide Transcriptional Profiles of Primary Hepatocytes in Collagen Sandwich and Monolayer Cultures
Yeonhee Kim et al.
TISSUE ENGINEERING PART C-METHODS (2010)
Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes
Sudipta Saha et al.
TOXICOLOGY LETTERS (2010)
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Shu-Feng Zhou et al.
DRUG METABOLISM REVIEWS (2009)
Genetic susceptibility to diclofenac-induced hepatotoxicity: Contribution of UGT2B7, CYP2C8, and ABCC2 genotypes
Ann K. Daly et al.
GASTROENTEROLOGY (2007)
Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: A comparative study in vitro
M. Turpeinen et al.
XENOBIOTICA (2007)
Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures
Grectje Elaut et al.
CURRENT DRUG METABOLISM (2006)
Acetaminophen-induced hepatotoxicity
LP James et al.
DRUG METABOLISM AND DISPOSITION (2003)
Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer status
ML Barclay et al.
PHARMACOGENETICS (2003)
Polymorphic hydroxylation of perhexiline in vitro
LB Sorensen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Infection of a human hepatoma cell line by hepatitis B virus
P Gripon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytes
NJ Hewitt et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2002)
分享论文
